Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q74599522)
Watch
English
A review of the pharmacology and clinical activity of new chemotherapeutic agents in lung cancer
scientific article published on 01 February 1998
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9606367
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606367%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
A review of the pharmacology and clinical activity of new chemotherapeutic agents in lung cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9606367
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606367%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 November 2019
main subject
chemotherapy
1 reference
based on heuristic
inferred from title
lung cancer
1 reference
based on heuristic
inferred from title
author
S. Vincent Rajkumar
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9606367
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606367%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 November 2019
author name string
A A Adjei
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9606367
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606367%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 November 2019
publication date
1 February 1998
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9606367
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606367%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 November 2019
published in
Cancer Treatment Reviews
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9606367
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606367%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 November 2019
volume
24
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9606367
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606367%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 November 2019
issue
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9606367
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606367%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 November 2019
page(s)
35-53
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9606367
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606367%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 November 2019
cites work
Cancer statistics, 1997.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy of lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multimodality treatment of stage IIIA non-small-cell lung carcinoma: a critical review of the literature and strategies for future research
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of external radiation and brachytherapy in unresectable non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the radiation therapy oncology group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lack of apparent difference in outcome between clinically staged IIIA and IIIB non-small-cell lung cancer treated with radiation therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of tumor control on survival in carcinoma of the lung treated with irradiation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of metastatic non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New drugs for treating small cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Small cell lung cancer: etiology, biology, clinical features, staging, and treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New drugs in non-small cell lung cancer. An overview
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanism of action of taxol
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel (taxol)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of Taxotere on murine and human tumor cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Motility and invasive potency of murine T-lymphoma cells: effect of microtubule inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro studies of Taxol as a radiation sensitizer in human tumor cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The taxoids: paclitaxel and docetaxel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel premedication regimens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low doses of dexamethasone protect against paclitaxel (Taxol)-related hypersensitivity reactions following cycle 1
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety profile of single-dose dexamethasone premedication for paclitaxel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Taxol-requiring mutant of Chinese hamster ovary cells with impaired mitotic spindle assembly
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Taxol resistant mutants of Chinese hamster ovary cells: genetic biochemical, and cross-resistance studies.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cremophor pharmacokinetics in patients receiving 3-, 6-, and 24-hour infusions of paclitaxel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study with paclitaxel for the treatment of advanced inoperable non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of docetaxel (Taxotere) in small cell lung cancer. The Early Clinical Trials Group of the EORTC.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of irinotecan and its metabolites in human blood, bile, and urine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CPT-11 Converting Enzyme from Rat Serum: Purification and Some Properties
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacologic study of topotecan in patients with impaired renal function
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacologic studies of topotecan in patients with impaired hepatic function
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of topotecan in metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical, toxicological and pharmacological aspects of gemcitabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Advanced breast cancer: a phase II trial with gemcitabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preclinical characteristics of gemcitabine.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiosensitizing nucleosides
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine in non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I clinical, plasma, and cellular pharmacology study of gemcitabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vinorelbine high-affinity binding to human platelets and lymphocytes: distribution in human blood
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Kinetic Analysis of Combination Effect of Navelbine (KW-2307) with Cisplatin against Human Lung Adenocarcinoma PC-12 Cells in Culture
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin-vinorelbine combination chemotherapy in locally advanced non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I-II study of vinorelbine (Navelbine) plus cisplatin in advanced non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carboplatin and vinorelbine in advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of vinorelbine in heavily previously treated small cell lung cancer. Japan Lung Cancer Vinorelbine Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990070-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0305-7372(98)90070-6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9606367
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606367%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 November 2019
PubMed publication ID
9606367
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9606367
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606367%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit